MwanzoRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Bei iliyotangulia
$ 7.26
Bei za siku
$ 6.78 - $ 7.08
Bei za mwaka
$ 5.60 - $ 15.74
Thamani ya kampuni katika soko
2.69B USD
Wastani wa hisa zilizouzwa
16.46M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 26.08M | 147.62% |
Matumizi ya uendeshaji wa biashara | 37.76M | 29.31% |
Mapato halisi | -95.84M | -3.04% |
Kiwango cha faida halisi | -367.46 | 58.39% |
Mapato kwa kila hisa | -0.34 | 20.93% |
EBITDA | -91.16M | 0.89% |
Asilimia ya kodi ya mapato | -0.17% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 427.65M | 10.41% |
Jumla ya mali | 726.50M | 15.17% |
Jumla ya dhima | 201.94M | 4.71% |
Jumla ya hisa | 524.56M | — |
hisa zilizosalia | 286.84M | — |
Uwiano wa bei na thamani | 3.97 | — |
Faida inayotokana na mali | -32.73% | — |
Faida inayotokana mtaji | -38.14% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -95.84M | -3.04% |
Pesa kutokana na shughuli | -59.22M | 18.78% |
Pesa kutokana na uwekezaji | -4.56M | -1,214.70% |
Pesa kutokana na ufadhili | 16.46M | -69.38% |
Mabadiliko halisi ya pesa taslimu | -46.92M | -139.19% |
Mtiririko huru wa pesa | -16.60M | 70.89% |
Kuhusu
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.
The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Makao Makuu
Tovuti
Wafanyakazi
500
